BIO is expected to report earnings to fall 9.31% to $2.63 per share on April 24
Q1'25
Est.
$2.63
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.85
Q2'24
Beat
by $1.10
Q1'24
Beat
by $0.14
The last earnings report on February 13 showed earnings per share of $2.90, beating the estimate of $2.86. With 334.71K shares outstanding, the current market capitalization sits at 9.79B.